A previous study identified gBRCA1/2 mutation as a risk factor for ovarian cancer brain metastasis, particularly the BRCA1 mutation, with 68.2 % (15 of 22 patients) showing loss of BRCA1 expression in the tumor (Szarszewska et al., 2019). This evidence concerns the gene BRCA1 and neoplasm.